Bio-Gene Technology Limited logo

Bio-Gene Technology Limited (BGT)

Market Open
ASX ASX
7.65M Market Cap
- P/E Ratio
- Div Yield
4,095 Volume
0 Eps
Want to track BGT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Bio-Gene Technology Limited logo
BGT Bio-Gene Technology Limited
25 Feb 2026
-
-
Bio-Gene Technology Limited logo
BGT Bio-Gene Technology Limited
25 Aug 2025
-
-
Bio-Gene Technology Limited logo
BGT Bio-Gene Technology Limited
27 Jul 2025
-
-
Bio-Gene Technology Limited logo
BGT Bio-Gene Technology Limited
24 Feb 2025
-
-
Bio-Gene Technology Limited logo
BGT Bio-Gene Technology Limited
22 Nov 2024
-
-
Bio-Gene Technology Limited logo
BGT Bio-Gene Technology Limited
31 Oct 2024
-
-
Bio-Gene Technology Limited logo
BGT Bio-Gene Technology Limited
28 Aug 2024
-
-
Bio-Gene Technology Limited logo
BGT Bio-Gene Technology Limited
26 Jul 2024
-
-
Bio-Gene Technology Limited logo
BGT Bio-Gene Technology Limited
29 Apr 2024
-
-
Bio-Gene Technology Limited logo
BGT Bio-Gene Technology Limited
21 Feb 2024
-
-
Bio-Gene Technology Limited logo
BGT Bio-Gene Technology Limited
30 Oct 2023
-
-

BGT Earnings Reports FAQ

What is the earnings per share (EPS) for BGT?

The current EPS is 0.

What is the company's earnings growth rate?

Bio-Gene Technology Limited has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Bio-Gene Technology Limited has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Bio-Gene Technology Limited are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for BGT at this time, as Bio-Gene Technology Limited has no recent EPS data to calculate it.